DUOPHARMA BIOTECH BERHAD

KLSE (MYR): DPHARMA (7148)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

1.38

Today's Change

+0.01 (0.73%)

Day's Change

1.35 - 1.38

Trading Volume

632,600


13 people like this.

12,450 comment(s). Last comment by KingKKK 1 week ago

invester

265 posts

Posted by invester > 2015-07-09 10:54 | Report Abuse

Already happened for at least 3 rounds till now

oregami

1,999 posts

Posted by oregami > 2015-07-09 10:55 | Report Abuse

married deal.

Posted by David Liu > 2015-07-14 10:40 | Report Abuse

When will we be getting the rights shares if we have subscribed?

mfed12

48 posts

Posted by mfed12 > 2015-07-15 17:26 | Report Abuse

rights shares listing on 22 july

euniceeng

13 posts

Posted by euniceeng > 2015-07-23 10:14 | Report Abuse

Is the right issue shares deposited?

necro

4,726 posts

Posted by necro > 2015-07-23 15:12 | Report Abuse

Yup that why volume doubling n tripling from average volume...
Seller must come from below RM3.80 buy price

Mohd Iqbal

266 posts

Posted by Mohd Iqbal > 2015-07-26 15:01 | Report Abuse

ccmdbio acquired all pharma divisions from ccm. How the purchase paid? by cash or share? when payment due to ccm?

johnny cash

6,400 posts

Posted by johnny cash > 2015-07-30 07:13 | Report Abuse

CCM Duopharma Biotech Bhd forms bullish "Symmetrical Continuation Triangle" chart pattern
Jul 23, 2015

Recognia has detected a "Symmetrical Continuation Triangle (Bullish)" chart pattern formed on CCM Duopharma Biotech Bhd (CCMDBIO:MYX). This bullish signal indicates that the stock price may rise from the close of 2.86 to the range of 3.31 - 3.41. The pattern formed over 45 days which is roughly the period of time in which the target price range may be achieved, according to standard principles of technical analysis.

Tells Me: The price has broken upward out of a consolidation period, suggesting a continuation of the prior uptrend. A Symmetrical Continuation Triangle (Bullish) shows two converging trendlines as prices reach lower highs and higher lows. Volume diminishes as the price swings back and forth between an increasingly narrow range reflecting uncertainty in the market direction. Then well before the triangle reaches its apex, the price breaks out above the upper trendline with a noticeable increase in volume, confirming the pattern as a continuation of the prior uptrend.

This bullish pattern can be seen on the following chart and was detected by Recognia proprietary pattern recognition technology.


DATED 23 JULY OLD BUT HELPFULL... CIMB TRADING IDEAS

atan

1 posts

Posted by atan > 2015-08-20 21:27 | Report Abuse

any dividends to be paid out soon?

dextronium

282 posts

Posted by dextronium > 2015-08-25 20:45 | Report Abuse

dividend 4 sen per unit.
revenue increased but operating costs also increased (administration/operating expenses) causes operating margin to drop from 25.3% (6/2014) to 15.3% (6/2015). Can't get further details at the moment...anybody want to shed some lights into? thanks in advance for any input....

KowChye

181 posts

Posted by KowChye > 2015-09-09 09:48 | Report Abuse

CCM Duopharma: Posts lower 2Q earnings on expenses. CCM Duopharma Biotech’s earnings fell 22.1% to RM5.9m from RM7.5m a year ago due to expenses involving a corporate exercise and payment to unionised staff following the signing of a collective agreement with the unionised staff. It said it revenue rose 38.6% to RM56.3m from RM40.6m due to RM13.1m revenue contributions from its newly acquired subsidiary companies with effect from June 1, 2015. (StarBiz)

necro

4,726 posts

Posted by necro > 2015-09-09 10:51 | Report Abuse

Its due to combine cost of new subsidiaries wrote on quater result... CCMDBIO should start enhances its consolidation purpose effectively by combine 2 separated product into single product since both CCMDBIO & CCMPHARMACEUTICAL ARMS+UPHA also produce the same generic..I think the proces won't take longer period to be solve...

necro

4,726 posts

Posted by necro > 2015-09-09 10:59 | Report Abuse

They must focuses high margin drug especially new expired patent cliff drug especially hypertension and cardiovascular drug ...

necro

4,726 posts

Posted by necro > 2015-09-09 11:11 | Report Abuse

Technical wise to journey high is must close above RM2.69

ridah118

266 posts

Posted by ridah118 > 2015-09-15 21:52 | Report Abuse

support support

necro

4,726 posts

Posted by necro > 2015-09-15 22:19 | Report Abuse

Wow CCM makan untung atas angin!!!

http://www.bursamalaysia.com/market/listed-companies/company-announcements/4867749

ridah118

266 posts

Posted by ridah118 > 2015-09-17 10:07 | Report Abuse

ccm majulah laki ni!

necro

4,726 posts

Posted by necro > 2015-09-17 13:06 | Report Abuse

Sell ASAP!!!

ridah118

266 posts

Posted by ridah118 > 2015-09-18 18:22 | Report Abuse

sell? sudden hike today! something 'fishy'

necro

4,726 posts

Posted by necro > 2015-09-18 20:35 | Report Abuse

CCM Marketing buyinglah

necro

4,726 posts

Posted by necro > 2015-10-06 00:06 | Report Abuse

The Malaysian healthcare system relies heavily on generic medicines. The more new medicine that enters the Malaysian market after signing the TPPA the more varieties of generic medicines there will be once the patent protection term expires.

Investeye

2,347 posts

Posted by Investeye > 2015-10-12 08:10 | Report Abuse

From Star newspaper:
Pharmaceutical research and development leads to the discovery of future life-changing and life-saving medicines. After patents expire, generic versions of innovative drugs continue to be widely used for decades, generating enormous health benefits for consumers. Malaysia stands to benefit through increased investment from multinational companies in the areas of research and development and clinical trials, potentially helping to build a local industrial base, and encourage the entry of more innovative products to the domestic market.

The issue of government procurement has also been raised during negotiation. According to the World Trade Organisation, government procurement accounts for some 15% to 20% of GDP on average in TPPA-related countries. Many TPPA partner countries, including the United States, have government procurement set asides in their respective countries.

With the TPPA, Malaysian-owned businesses will have opportunities to participate in government procurement in TPPA member countries. This promotes competitive neutrality and a level playing field among TPPA members. We foresee that the final text of the TPPA will have some level of appropriate discretion for procurement with participating governments.

Investeye

2,347 posts

Posted by Investeye > 2015-10-12 10:09 | Report Abuse

As this counter is behind present price up, may provide a good opportunity to accumulate at present or any price down for both Hovid and CCMDBIO.

GEORGE TOWN: The Health Mi­­nistry rejects the proposal by the United States to extend the expiry date of patents of medicines in the Trans-Pacific Partnership Agreement (TPPA) for the medical sector.

Deputy Health Minister Datuk Seri Dr Hilmi Yahaya said the duration of the patents should be reduced to enable a particular nation to produce generic medicines.

Previously, he said, the duration was 20 years, but the United States had suggested recently that the duration be extended to protect intellectual property rights.

“The Health Ministry has announ­ced that we do not agree on the extension of the duration of patency of the medicines as it will burden the people,” he said after launching the “Pesta Tanglung Universiti Sains Malaysia”.

He said the production of generic medicines would not be allowed du­­ring the patent period if the US proposal was accepted. — Bernama

Investeye

2,347 posts

Posted by Investeye > 2015-10-12 15:25 | Report Abuse

Since this counter price stagnant due to present index up, take opportunity to accumulate few lots at RM2.68

Investeye

2,347 posts

Posted by Investeye > 2015-10-12 22:34 | Report Abuse

Will accumulate more when price drop further.. in fact, CCMDBIO should perform better for 2nd half.

Investeye

2,347 posts

Posted by Investeye > 2015-10-13 16:30 | Report Abuse

Further accumulated at rm2.59, this price is just after ex-date if 4 cents dividend

Posted by FreedomStrike > 2015-11-05 19:41 | Report Abuse

any news for this counter? has been static for so many days already..

Bb96

1 posts

Posted by Bb96 > 2015-11-21 20:37 | Report Abuse

Buy now or wait som more?

pc007

237 posts

Posted by pc007 > 2016-01-09 09:13 | Report Abuse

After acquisition, revenue climbing up significantly.... positive news to share holder. Collect more now before too late

Posted by U Tang Tang > 2016-01-09 15:09 | Report Abuse

我觉得ccmdbio是第2个topglove。。。长线投资会有不错的回报

erkongseng

3,192 posts

Posted by erkongseng > 2016-02-13 11:23 | Report Abuse

2.68 buy in

Posted by Lenard Hwee > 2016-02-24 00:32 | Report Abuse

good result but bad for dividend compared to last year

necro

4,726 posts

Posted by necro > 2016-02-24 11:04 | Report Abuse

Dividend is adjusted for 1:1 right issue lah bro...

Superb99

6,599 posts

Posted by Superb99 > 2016-02-24 17:12 | Report Abuse

not attractive, only 3.6% dividend yield, 0.095/2.64

necro

4,726 posts

Posted by necro > 2016-02-25 10:00 | Report Abuse

MOH approve the using of insulin recombant in its facility starting 2017+2018(renewal according to term) to replace insulman which using for 2years(2015+2016) ...
Should give a kick in revenue & hopefully profit

Superb99

6,599 posts

Posted by Superb99 > 2016-03-02 17:14 | Report Abuse

i will buy more if it drops below 2.5

Investeye

2,347 posts

Posted by Investeye > 2016-03-21 12:11 | Report Abuse

With it bought over few medicine factories on potential growth and dividend matched the fd rate. It is worth to look at counter for mid & long term investment due to present very reasonable price at around rm2.52...

Investeye

2,347 posts

Posted by Investeye > 2016-03-22 10:31 | Report Abuse

Accumulated at rm2.51...

Investeye

2,347 posts

Posted by Investeye > 2016-03-22 21:11 | Report Abuse

KUALA LUMPUR (March 22): CCM Duopharma Biotech Bhd (CCMD) is building a RM103.7 million state-of-the-art plant, together with a RM37.1 million warehouse with rooftop car park in Taman Klang Jaya, Selangor, to meet its growing operations and portfolio expansion.
In a bourse filing today, CCMD said the plant, which consists of two adjoining blocks, will be equipped with enhanced current good manufacturing practices (cGMP) facilities to cater for existing businesses and increased product offerings, including specialty products.
"The new plant will house the oral solid dosage (OSD) manufacturing facility, including specialty product manufacturing site, quality control (QC) and quality assurance (QA) and administrative office," it said.
The completion of the plant will cater to the future expansion plans of CCMD, and will up its production capacity by about 40% to 50%.
Its existing plant located in Klang was constructed in 1994 and currently houses the QC, QA, OSD and haemodialysis manufacturing facilities, said CCMD.
"The construction of the new plant is necessary to meet the demand of the growing current operations and expanding the current portfolio into specialty products as well as to keep abreast with cGMP," it added.
The new buildings are expected to complement each other and will serve as CCMD's central point for its designated activities.
Construction of the new buildings, which should start in the third quarter of this year, is expected to be completed in the fourth quarter of 2018.
The capital expenditure will be partially funded with proceeds from the rights issue exercise conducted in 2015 (which amounted to RM113.3 million), with the balance to come from a combination of internally generated funds and/or external borrowings.
CCMD shares closed three sen or 1.19% lower at RM2.49 today, valuing it at RM694.6 million

Investeye

2,347 posts

Posted by Investeye > 2016-03-24 10:05 | Report Abuse

Take opportunity to further accumulate..

Posted by smartInvestor1 > 2016-04-11 15:51 | Report Abuse

Queue at 2.45 and 2.40.

Posted by U Tang Tang > 2016-04-28 21:53 | Report Abuse

有没坏消息?

Angielim9955

2,049 posts

Posted by Angielim9955 > 2016-04-29 16:21 | Report Abuse

joshuacfy why such high divided this price will down ?
any bad news can update me please ?

Investeye

2,347 posts

Posted by Investeye > 2016-05-11 19:49 | Report Abuse

Further accumulated few lot today as i think further down is limited and dividend is reasonable.

iphone4

132 posts

Posted by iphone4 > 2016-05-12 15:22 | Report Abuse

If based on price to BV and dividend yield aft the Rights, the price downside is still high. Any good reason why u guys want to buy in at this price.

Posted by prescott2006 > 2016-05-31 17:01 | Report Abuse

Bought 22 lots at RM2.24, such a wonderful company, consistently high ROE, low D/E, a lot of cash. Still wondering why nobody found this gem.

Investeye

2,347 posts

Posted by Investeye > 2016-06-01 16:17 | Report Abuse

I did further collected few lots recently at it business is stable, better than fd rate, expansion of it business..

Investeye

2,347 posts

Posted by Investeye > 2016-06-01 16:28 | Report Abuse

It is strange that some lots done but the selling volume still sticked to 2 lots, push and kept the price down?

Posted by prescott2006 > 2016-06-01 20:14 | Report Abuse

Don't have to worry too much about the price movement. They are just noise. This is Buffett kind of stock, consistently high ROE, easy to understand business, keep it for life.

Investeye

2,347 posts

Posted by Investeye > 2016-06-02 15:05 | Report Abuse

Keep for mid or longer term ..but not for life if there is netter opportunity or the performance is getting loose

Post a Comment